CCTU- Cancer Theme
19
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
5.3%
1 terminated/withdrawn out of 19 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer
Role: lead
Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)
Role: lead
Metabolic and Immunological Phenotyping in Patients With Cancer
Role: lead
WIRE - Novel Treatments in Renal Cell Cancer
Role: lead
A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer
Role: lead
Microbiome Immunotherapy Toxicity and Response Evaluation
Role: lead
Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV Melanoma
Role: lead
Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy
Role: lead
Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible
Role: lead
AZD6738 & Gemcitabine as Combination Therapy
Role: lead
A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 Pneumonitis
Role: lead
Evaluation of Novel Diagnostic Tests for COVID-19
Role: lead
Therapeutics in Active Prostate Cancer Surveillance
Role: lead
LUCID - LUng Cancer CIrculating Tumour Dna Study
Role: lead
Identification of Novel Biomarkers of Response to Systemic Treatments in Renal Cell Cancer
Role: lead
To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers
Role: lead
Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials
Role: lead
Scheduling Nab-paclitaxel With Gemcitabine
Role: lead
Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)
Role: lead
All 19 trials loaded